SAN CARLOS, Calif.--(BUSINESS WIRE)--June 21, 2005--Cellerant Therapeutics announced today that it has been named to FierceBiotech's annual Fierce 15 list. This distinction honors Cellerant as one of the top 15 emerging biotech companies for 2005. FierceBiotech, an internationally recognized email newsletter covering the biotechnology and pharmaceutical markets, evaluated hundreds of privately-held firms based on company vision, revenue potential, quality of deals, strength of technology, partnerships, and competitive market position.
"Cellerant is in a race to create the first approved product from adult stem cells and they think they may be within 18 months of having their first product on the market. That's no easy task," said John Carroll, of FierceBiotech. "Like the other swiftly developing companies on this year's Fierce 15 list, we'll be watching Cellerant closely in the years ahead."
